Thrombopenia Clinical Trial
Official title:
Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.
About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.
About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares. ;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT05040776 -
COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients
|
Phase 2 | |
| Recruiting |
NCT02906878 -
Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter
|
N/A | |
| Not yet recruiting |
NCT06455553 -
Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.
|
N/A | |
| Completed |
NCT01013181 -
Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults
|
N/A | |
| Not yet recruiting |
NCT03823079 -
Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia
|
Phase 2 | |
| Completed |
NCT04070599 -
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
|
Phase 3 |